Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Vaccine Wanna-be iBio Stock Remains a Gamble Even After New Partnership

By Larry Sullivan, InvestorPlace contributor
A recent deal on developing a Covid-19 therapy is getting attention but IBIO stock is still a very speculative play in the biopharma space.

Here’s Why Moderna Shares May Blast Higher Over the Next Few Weeks

By Chris Lau, InvestorPlace Contributor
Moderna’s R&D day was a non-event, while upcoming clinical data posts may re-ignite MRNA stock buying.

Pros and Cons to Consider for When the Airbnb IPO Finally Comes to Market

By Josh Enomoto, InvestorPlace Contributor
Before the pandemic, many investors eagerly anticipated the Airbnb IPO. After the novel coronavirus did its damage, should people believe in the rescheduled debut?

Unity Software IPO: 12 Things for Potential U Stock Investors to Know

By William White, InvestorPlace Writer
The Unity Software (U) initial public offering (IPO) is underway and it's already looking good for the game engine developer.

Cassava Sciences News: SAVA Stock Surges 38% on Insider Buying

By William White, InvestorPlace Writer
Cassava Sciences (SAVA) news for Friday concerning insider buying from leaders at the company has SAVA stock on the rise.

Novavax Stock Is a Solid Bet on Vaccine Hopes

By InvestorPlace Research Staff
The case for NVAX stock is simple: vaccine approval should lead to a significant rally. With progress continuing and the stock cheaper, that case holds.

AI News: Veritone (VERI) Stock Soars 15% on U.S. Air Force Subcontracts

By William White, InvestorPlace Writer
AI-company Veritone (VERI) is seeing its stock take off Friday following news of a 1.3 million deal with the U.S Air Force.

Why the Perplexing Science of Vaccines Keeps Novavax Around

By Josh Enomoto, InvestorPlace Contributor
Though Novavax is behind in the clinical trial race, that doesn’t necessarily mean NVAX stock is done for. However, investors who want to take a bet must do so very carefully.

Flipkart IPO? 15 Things for Potential Investors to Know

By William White, InvestorPlace Writer
Flipkart is reportedly planning an initial public offering (IPO) and InvestorPlace has everything potential investors need to know about it.

LLNW Stock: Why Limelight Networks Stock Is Surging Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Limelight Networks is racking some analyst love thanks to its role as a content delivery network. Here's what to know about LLNW stock.

Walmart Pay Raise 2020: 165,000 Employees to Get Wage Increase

By William White, InvestorPlace Writer
A Walmart (WMT) pay raise is coming in 2020 as the company changes how its business operates to benefits some of its employees.

How to Pull Profits out of Dead-Money Virgin Galactic

By Tyler Craig, Tales of a Technician
Virgin Galactic offers little hope for directional trades right now. Embrace the SPCE stock neutrality with these options strategies.

iBio Is a Wishful Thinkers Coronavirus Vaccine Bet

By Muslim Farooque, InvestorPlace Contributor
IBIO stock isn't the coronavirus vaccine bet investors should pursue, with its candidates in pre-clinical stages showing minimal promise.

United States Steel News: Why X Stock Is Surging 6% Today

By William White, InvestorPlace Writer
United States Steel (X) news for Friday includes positive guidance for the third quarter of the year sending X stock higher.

Roche Stock Rallies on Promising Coronavirus Drug Results

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Roche stock is rallying Friday on news that Actemra, an anti-inflammatory drug from the Swiss company, may help coronavirus patients.

Why Plug Power Is Sinking to Zero While a Rising Tide Lifts Other Boats

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
PLUG stock looks set to implode unless something drastic changes in its technology. Insiders aren't waiting to see.

How Far Can Workhorse Stock Rally From Here?

By Bret Kenwell, InvestorPlace Contributor
Workhorse has been on fire, hitting new high after new highs. Let's take a look at the charts to see how far WKHS stock can go.

Germany Makes a $299 Million Bet on CureVac

By Will Ashworth, InvestorPlace Contributor
CureVac recently was awarded $299 million to support the development of its Covid-19 vaccine. What does this mean for CureVac stock?  

The Compelling Science and the Harsh Risks Behind Inovio Pharmaceuticals

By Josh Enomoto, InvestorPlace Contributor
Although vaccine plays are inherently risky, the recent robust rally in INO stock is backed by strong and compelling science.
Load More Articles